Finance

Lists
4118:TYO
Kaneka Corp
6 061,00 JP¥
+0,98%
(+59,00) 1D
13-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4118...
Open
6 019 JP¥
High
6 066 JP¥
Low
5 984 JP¥
Mkt. cap
381,84 млд
Avg. vol.
204,38 миң
Volume
137,70 миң
Dividend
2,64%
Quarterly dividend
40 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
10,40
52-wk high
6 570 JP¥
52-wk low
4 082 JP¥
EPS
583 JP¥
Shares outstanding
65,56 млн
No. of employees
12 миң
Open
6 019 JP¥
High
6 066 JP¥
Low
5 984 JP¥
Mkt. cap
381,84 млд
Avg. vol.
204,38 миң
Volume
137,70 миң
Dividend
2,64%
Quarterly dividend
40 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
10,40
52-wk high
6 570 JP¥
52-wk low
4 082 JP¥
EPS
583 JP¥
Shares outstanding
65,56 млн
No. of employees
12 миң
News stories
From web sources and news partners
Profile
Kaneka Corporation is a Japanese international chemical manufacturing company based in Osaka. The company was founded in 1949 and produces chemical products such as functional resin, foam resin, and synthetic fibers. The company was also engaged in the medical equipment business. In recent years, the company manufactured raw material for production of coenzyme Q10, and apheresis devices, where blood of a donor or patient is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. Wikipedia
About Kaneka Corp
CEO-
Employees11,8 миң
Founded1949-ж., 1-сен.
Headquarters-
SectorCommodity chemical
Last report
2026-ж., 13-авг.
Fiscal period
Q1 2027
- / -
Revenue / Est. (JPY)
223,02 млд / 205,80 млд
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
198,75 млд
200,85 млд
213,36 млд
223,02 млд
Cost of goods sold
144,43 млд
144,80 млд
152,38 млд
157,45 млд
Cost of revenue
144,43 млд
144,80 млд
152,38 млд
157,45 млд
Research and development expenses
-
-
39,89 млд
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47,51 млд
48,81 млд
847,00 млн
50,64 млд
Operating expense
47,51 млд
48,81 млд
51,54 млд
50,64 млд
Total operating expenses
191,94 млд
193,62 млд
203,92 млд
208,08 млд
Operating income
6,80 млд
7,23 млд
9,44 млд
14,94 млд
Other non operating income
-332,00 млн
-340,00 млн
1,29 млд
-222,00 млн
EBT including unusual items
9,96 млд
11,33 млд
16,62 млд
13,42 млд
EBT excluding unusual items
6,27 млд
7,98 млд
10,87 млд
14,69 млд
Income tax expense
2,74 млд
3,58 млд
3,60 млд
3,92 млд
Effective tax rate
27,56%
31,57%
21,67%
29,24%
Other operating expenses
-
-
-
-
Net income
6,79 млд
7,39 млд
12,54 млд
8,94 млд
Net profit margin
3,42%
3,68%
5,88%
4,01%
Earnings per share
-
-
-
-
Interest and investment income
235,00 млн
771,00 млн
385,00 млн
675,00 млн
Interest expense
-1,01 млд
-1,00 млд
-1,07 млд
-1,09 млд
Net interest expenses
-775,00 млн
-229,00 млн
-682,00 млн
-419,00 млн
Depreciation and amortization charges
-
-
10,80 млд
-
EBITDA
18,40 млд
18,22 млд
21,30 млд
26,80 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору